Development of Celiac Disease Therapeutics: Report of the Third Gastroenterology Regulatory Endpoints and Advancement of Therapeutics Workshop

被引：21

作者：

Leffler, Daniel ^{[1
]}

Kupfer, Sonia S. ^{[2
]}

Lebwohl, Benjamin ^{[3
]}

Bugin, Kevin ^{[4
]}

Griebel, Donna ^{[4
]}

Lathrop, Julia Tait ^{[4
]}

Lee, Jessica J. ^{[4
]}

Mulberg, Andrew E. ^{[4
]}

Papadopoulos, Elektra ^{[4
]}

Tomaino, Juli ^{[4
]}

Crowe, Sheila E. ^{[5
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA

[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA

[3] Columbia Univ, Dept Med, New York, NY USA

[4] US FDA, Silver Spring, MD USA

[5] Univ Calif San Diego, Dept Med, 9500 Gilman Dr,BRF 2,Off 4A30, La Jolla, CA 92093 USA

来源：

GASTROENTEROLOGY | 2016年 / 151卷 / 03期

关键词：

GLUTEN-FREE DIET; PREDICTORS; ANTIBODIES; DIAGNOSIS; MORTALITY; SYMPTOMS; ADULTS;

D O I：

10.1053/j.gastro.2016.07.025

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

[No abstract available]

引用

页码：407 / 411

页数：5

共 50 条

[21] The regulatory functions of microglia in brain development and their application possibility in the drug development and therapeutics
Sato, Kaoru
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S29 - S29
[22] An introduction to biosimilar cancer therapeutics: definitions, rationale for development and regulatory requirements
Buske, Christian
Ogura, Michinori
Kwon, Hyuk-Chan
Yoon, Sang Wook
FUTURE ONCOLOGY, 2017, 13 (15) : 5 - 16
[23] FDA Designations for Therapeutics and Their Impact on Drug Development and Regulatory Review Outcomes
Kesselheim, A. S.
Darrow, J. J.
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 (01) : 29 - 36
[24] A Report on the International Transglutaminase Autoantibody Workshop for Celiac Disease
Li, Marcella
Yu, Liping
Tiberti, Claudio
Bonamico, Margherita
Taki, Iman
Miao, Dongmei
Murray, Joseph A.
Rewers, Marian J.
Hoffenberg, Edward J.
Agardh, Daniel
Mueller, Patricia
Stern, Martin
Bonifacio, Ezio
Liu, Edwin
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (01): : 154 - 163
[25] Therapeutics development for Ebola virus disease: A recent scenario
Chakraborty, Chiranjib
CURRENT OPINION IN PHARMACOLOGY, 2021, 60 : 208 - 215
[26] Development of histone deacetylase inhibitors as therapeutics for neurological disease
Gottesfeld, Joel M.
Pandolfo, Massimo
FUTURE NEUROLOGY, 2009, 4 (06) : 775 - 784
[27] Molecular Therapeutics in Development to Treat Alzheimer's Disease
Tartaglia, Maria Carmela
Ingelsson, Martin
MOLECULAR DIAGNOSIS & THERAPY, 2025, 29 (01) : 9 - 24
[28] Development of MicroRNA-Based Therapeutics for Vascular Disease
Jones, Kia J.
Searles, Charles D.
CIRCULATION RESEARCH, 2020, 127 (09) : 1179 - 1181
[29] Huntington Disease: Linking Pathogenesis to the Development of Experimental Therapeutics
Mestre, Tiago A.
Sampaio, Cristina
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2017, 17 (02)
[30] Leveraging preclinical models for the development of Alzheimer disease therapeutics
Kimberly Scearce-Levie
Pascal E. Sanchez
Joseph W. Lewcock
Nature Reviews Drug Discovery, 2020, 19 : 447 - 462

← 1 2 3 4 5 →